The diagnostic significance of IgG cow's milk protein antibodies re-evaluated

1996 ◽  
Vol 155 (4) ◽  
pp. 331-337 ◽  
Author(s):  
K. M. Keller ◽  
A. Bürgin-Wolff ◽  
Rainer Lippold ◽  
Stefan Wirth ◽  
Michael J. Lentze
Keyword(s):  
Milk Protein ◽  
Cow’S Milk ◽  
Diagnostic Significance ◽  
Cow's Milk ◽  
Cow’S Milk Protein ◽  
Cow's Milk Protein Antibodies

The diagnostic significance of IgG cow's milk protein antibodies re-evaluated

1996 ◽  
Vol 155 (4) ◽  
pp. 331-337 ◽  
Author(s):  
Klaus M. Keller ◽  
Annemarie Bürgin-Wolff ◽  
Rainer Lippold ◽  
Stefan Wirth ◽  
Michael J. Lentze
Keyword(s):  
Milk Protein ◽  
Cow’S Milk ◽  
Diagnostic Significance ◽  
Cow's Milk ◽  
Cow’S Milk Protein ◽  
Cow's Milk Protein Antibodies

Influence of Breast Feeding on the Development of Cow’s Milk Protein Antibodies and the IgE Level

1984 ◽  
Vol 75 (1) ◽  
pp. 87-91 ◽  
Author(s):  
S.P. Fällström ◽  
S. Ahlstedt ◽  
B. Carlsson ◽  
B. Wettergren ◽  
L.Å. Hanson
Keyword(s):  
Breast Feeding ◽  
Milk Protein ◽  
Cow’S Milk ◽  
Cow's Milk ◽  
Cow’S Milk Protein ◽  
Cow's Milk Protein Antibodies

scholarly journals Diet, cow's milk protein antibodies and the risk of IDDM in Finnish children

Diabetologia ◽  
1994 ◽  
Vol 37 (4) ◽  
pp. 381-387 ◽  
Author(s):  
S. M. Virtanen ◽  
L. R�s�nen ◽  
H. K. �kerblom ◽  
T. Saukkonen ◽  
E. Savilahti ◽  
...  
Keyword(s):  
Milk Protein ◽  
Cow’S Milk ◽  
Cow's Milk ◽  
Cow’S Milk Protein ◽  
Cow's Milk Protein Antibodies

scholarly journals Diet, cow's milk protein antibodies and the risk of IDDM in Finnish children

Diabetologia ◽  
1994 ◽  
Vol 37 (4) ◽  
pp. 381-387 ◽  
Author(s):  
S. M. Virtanen ◽  
T. Saukkonen ◽  
E. Savilahti ◽  
K. Yl�nen ◽  
L. R�s�nen ◽  
...  
Keyword(s):  
Milk Protein ◽  
Cow’S Milk ◽  
Cow's Milk ◽  
Cow’S Milk Protein ◽  
Cow's Milk Protein Antibodies

scholarly journals Significance of cow's milk protein antibodies as risk factor for childhood IDDM: interactions with dietary cow's milk intake and HLA-DQB1 genotype

Diabetologia ◽  
1998 ◽  
Vol 41 (1) ◽  
pp. 72-78 ◽  
Author(s):  
T. Saukkonen ◽  
S. M. Virtanen ◽  
M. Karppinen ◽  
H. Reijonen ◽  
J. Ilonen ◽  
...  
Keyword(s):  
Risk Factor ◽  
Milk Protein ◽  
Milk Intake ◽  
Cow’S Milk ◽  
Cow's Milk ◽  
Childhood Iddm ◽  
Cow’S Milk Protein ◽  
Cow's Milk Protein Antibodies

scholarly journals O5 The prevalence of cow’s milk protein allergy in infants with gastroschisis and intestinal failure type 2 and 3

2021 ◽  
Author(s):  
Kornilia Nikaki ◽  
Tracey Johnson ◽  
Haidee Norton ◽  
Gabis Chana ◽  
Amrita Garcha ◽  
...  
Keyword(s):  
Milk Protein ◽  
Intestinal Failure ◽  
Cow’S Milk ◽  
Cow's Milk ◽  
Failure Type ◽  
Cow’S Milk Protein

scholarly journals Fecal Calprotectin and Eosinophil-Derived Neurotoxin in Children with Non-IgE-Mediated Cow’s Milk Protein Allergy

2021 ◽  
Vol 10 (8) ◽  
pp. 1595
Author(s):  
María Roca ◽  
Ester Donat ◽  
Ana Rodriguez Varela ◽  
Eva Carvajal ◽  
Francisco Cano ◽  
...  
Keyword(s):  
Milk Protein ◽  
Statistical Significance ◽  
Functional Gastrointestinal Disorders ◽  
Fecal Calprotectin ◽  
Cow’S Milk ◽  
Cow's Milk ◽  
Young Infants ◽  
Healthy Infants ◽  
Ige Mediated ◽  
Cow’S Milk Protein

Our aim is to assess the efficacy of fecal calprotectin (fCP) and fecal eosinophil-derived neurotoxin (fEDN) as diagnostic markers of cow’s milk protein allergy (CMPA) and for monitoring the infants’ response to a non-IgE mediated cow’s milk protein (CMP)-free diet. We prospectively recruited infants aged 0 to 9 months. Stool samples were taken from 30 infants with CMPA, 19 with mild functional gastrointestinal disorders, 28 healthy infants, and 28 children who presented mild infections. Despite the fact that levels of fCP and fEDN in CMPA infants were higher than in healthy infants at month 0, differences for both parameters did not reach statistical significance (p-value 0.119 and 0.506). After 1 month of an elimination diet, no statistically significant differences in fCP with basal levels were found (p-values 0.184) in the CMPA group. We found a high variability in the fCP and fEDN levels of young infants, and discrepancies in individual behavior of these markers after a CMP-free diet was started. It seems that neither fCP nor fEDN levels are helpful to discriminate between healthy infants and those with signs or symptoms related to non-IgE-mediated CMPA. Additionally, it is debatable if on an individual basis, fCP or fEDN levels could be used for clinical follow-up and dietary compliance monitoring. However, prospective studies with larger populations are needed to draw robust conclusions.

Sign in / Sign up

Export Citation Format

Share Document